Showing 1 to 2 of 2 clinical trials
CLINICAL TRIALS
    Trial No
    ClinicalTrials.gov ID
Phase Coordinator
An International, Phase 3, Randomized, Multicenter, Open-label Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated With Imatinib
    INSIGHT
    NCT05734105
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Alina Lungescu
514-934-1934
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
    Peak
    NCT05208047
     Recruiting
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
Samara Bloom
514-252-3400 poste 6244